Alvotech And Cipla Strike Biosimilars Alliance In South Africa

Deal Covers Five Undisclosed Biosimilars

 
• By Dean Rudge

Alvotech, fresh from a round of financing, has grand plans to market its biosimilar candidates across the globe. A new partnership just signed with South Africa-based Cipla Medpro will cover five candidates, including two in oncology.

running athletic race track with blending South Africa flag
The partnership provides for five biosimilars – two for oncology and three for treating autoimmune diseases – in certain emerging markets, including South Africa. • Source: Shutterstock

More from Biosimilars

More from Products